Chronic or delayed treatment with an oral dithiocarbamate analog decreases glycation and protects diabetic arteries

European Journal of Pharmacology

Volumn 472, Issue 1-2, 2003, Pages 127-134

  Pieper, Galen M ^a,b   Siebeneich, Wolfgang ^a   Olds, Cara L ^a   Lai, Ching San ^c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b FREE RADICAL RESEARCH CENTER   (United States)

^c Medinox Inc   (United States)

Author keywords

Diabetes mellitus; Endothelium; Glycated; Hemoglobin; Iron chelator; NF B (nuclear factor B)

Indexed keywords

ACETYLCHOLINE; DITHIOCARBAMIC ACID DERIVATIVE; DRINKING WATER; GLYCERYL TRINITRATE; GLYCOSYLATED HEMOGLOBIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NORADRENALIN; NOX 700; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA; ARTERY DILATATION; ARTICLE; BLOOD VESSEL REACTIVITY; CELL NUCLEUS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENDOTHELIUM LESION; GEL MOBILITY SHIFT ASSAY; LONG TERM EXPOSURE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN GLYCOSYLATION; RAT; STREPTOZOCIN DIABETES; VASCULAR ENDOTHELIUM; VASCULAR RING;

EID: 0038304896     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01861-2     Document Type: Article

References (42)

1. Angulo J., Sánchez-Ferrer C.F., Peiró C., Marín J., Rodríquez-Manas L. Impairment of endothelium-dependent relaxation by increasing percentages of glycosylated human hemoglobin. Possible mechanisms involved. Hypertension. 28:1996;583-592.
2. Bierhaus A., Chevion S., Chevion M. Advanced glycation end product-induced activation of NF-κB is suppressed by α-lipoic acid in cultured endothelial cells. Diabetes. 46:1997;1481-1490.
3. Bursell S.E., Clermont A.C., Aiello L.P., Aiello L.M., Schlossman D.K., Feener E.P., Laffel L., King G. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with Type 1 diabetes. Diabetes Care. 22:1999;1245-1251.
4. Cooper M., Lindholm P., Pieper G., Seibel R., Moore G., Nakanishi A., Dembny K., Komorowski R., Johnson C., Adams M., Roza A. Myocardial nuclear factor-κB activity and nitric oxide production in rejecting cardiac allografts. Transplantation. 66:1998;838-844.
5. Du X., Stockklauser-Färber K., Rösen P. Generation of reactive oxygen intermediates, activation of NF-(B and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase? Free Radic. Biol. Med. 27:1999;752-763.
6. Galle J., Schneider R., Winner B., Lehmann-Bodem C., Schinzel R., Münch G., Conzelmann E., Wanner C. Glyc-oxidized LDL impair endothelial function more potently than oxidized LDL: role of enhanced oxidative stress. Atherosclerosis. 138:1998;65-77.
7. Hattori Y., Banba N., Gross S.S., Kasai K. Glycated serum albumin-induced nitric oxide production in vascular smooth muscle cells by nuclear factor κB-dependent transcriptional activation of inducible nitric oxide synthase. Biochem. Biophys. Res. Commun. 259:1999;128-132.
8. Hink U., Li H., Mollnau H., Oelze M., Matheis E., Hartmann M., Skatchov M., Thaiss F., Stahl R.A.K., Warnholtz A., Meinertz T., Griendling K., Harrison D.G., Forstermann U., Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ. Res. 88:2001;e14-e22.
9. Hunt J.V., Dean R.T., Wolff S.P. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem. J. 256:1988;205-212.
10. ++-ATPase activities in high glucose-treated human erythrocytes. Free Radic. Biol. Med. 29:2000;1122-1128.
11. Jain S.K., Palmer M. The effect of oxygen radicals metabolites and vitamin E on glycosylation of proteins. Free Radic. Biol. Med. 22:1997;593-596.
12. Jain S.K., McVie R., Jaramillo J.J., Palmer M., Smith T. Effect of modest vitamin E supplementation on blood glycated hemoglobin and triglyceride levels and red cell indices in Type I diabetic patients. J. Am. Coll. Nutr. 15:1996;458-461.
13. Keegan A., Cotter M.A., Cameron N.E. Effects of diabetes and treatment with the antioxidant α-lipoic acid on endothelial and neurogenic responses of corpus cavernosum in rats. Diabetologia. 42:1999;343-350.
14. Kim J.A., Berliner J.A., Natarajan R.D., Nadler J.L. Evidence that glucose increases monocyte binding to human aortic endothelial cells. Diabetes. 43:1994;1103-1107.
15. Ludvigsson J., Samuelsson U., Johansson C., Stenhammar L. Treatment with antioxidants at onset of type I diabetes in children: a randomized, double-blind placebo-controlled study. Diabetes/Metab. Res. Dev. 17:2001;131-136.
16. Mankhetkorn S., Abedinzadeh Z., Houee-Levin C. Antioxidant action of sodium diethyldithiocarbamate: reaction with hydrogen peroxide and superoxide radical. Free Radic. Biol. Med. 17:1994;517-527.
17. Ou P., Tristchler H.J., Wolff S.P. Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant? Biochem. Pharmacol. 50:1995;123-126.
18. Packer L. α-Lipoic acid: a metabolic antioxidant which regulates NF-κB signal transduction and protects against oxidative injury. Drug Metab. Rev. 30:1998;245-265.
19. Pieper G.M. Review of alterations in endothelial nitric oxide production in diabetes. Protective role of arginine on endothelial dysfunction. Hypertension. 31:1998;1047-1060.
20. Pieper G.M. Hyperglycemia and diabetes induced vascular dysfunction: role of oxidative stress. Keaney J.F. Jr. Oxidative Stress and Vascular Disease. 2000;305-322 Kluwer Academic Publishing, Boston.
21. Pieper G.M., Dondlinger L.A. Antioxidant pyrrolidine dithiocarbamate prevents defective bradykinin-stimulated calcium accumulation and nitric oxide activity following exposure of endothelial cells to elevated glucose concentration. Diabetologia. 41:1998;612-806.
22. Pieper G.M., Siebeneich W. Diabetes-induced endothelial dysfunction is prevented by long-term treatment with the modified iron chelator hydroxyethyl starch conjugated-deferoxamine. J. Cardiovasc. Pharmacol. 30:1997;734-738.
23. Pieper G.M., Siebeneich W. Oral administration of the antioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction. J. Cardiovasc. Pharmacol. 32:1998;101-105.
24. Pieper G.M., ul-Haq R. Activation of nuclear factor-κB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. J. Cardiovasc. Pharmacol. 30:1997;528-532.
25. Pieper G.M., Siebeneich W., Olds C.L., Felix C.C., Del Soldato P. Vascular protective actions of a nitric oxide aspirin analog in both in vitro and in vivo models of diabetes mellitus. Free Radic. Biol. Med. 32:2002;1143-1156.
26. Qian M., Liu M., Eaton J.W. Transition metals bind to glycated proteins forming redox active 'glycochelates': implications for the pathogenesis of certain diabetic complications. Biochem. Biophys. Res. Commun. 250:1998;385-389.
27. Qian M., Brunk U.T., Pieper G.M., Eaton J.W. Diabetic peripheral neuropathy: possible involvement of iron bound to glycated basement membrane protein. Pediatr. Res. 43:1998;83A. (abstract).
28. Reaven P.D., Herold D.A., Barnett J., Edelman S. Effects of vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM. Diabetes Care. 18:1995;807-816.
29. Rodríguez-Manas L., Angulo J., Peiró C., Llergo J.L., Sánchez-Ferrer A., Lopez-Doriga P., Sanchez-Ferrer C.F. Endothelial dysfunction and metabolic control in streptozotocin-induced diabetic rats. Br. J. Pharmacol. 123:1998;1495-1502.
30. Roza A.M., Khanna A.K., Pieper G.M., Olds C.L., Baz R., Hilton G., Adams M.B. Effects of antioxidant therapy on alloimmune activation and NF-κB-dependent inflammatory gene expression. Am. J. Transplant. 1(Suppl. 1):2001;268. (abstract).
31. Roza A.M., Pieper G.M., Adams M.B., Lai C.S. Pancreatic NF-κB activation, iNOS gene expression and impact of NO scavenging in IDDM. Acta Chir. Austriaca. 33(suppl. 174):2001;73. (abstract).
32. Saxena A.K., Saxena P., Wu X., Obrenovich M., Weiss M.F., Monnier V.M. Protein aging by carboxymethylation of lysines generates sites for divalent metal and redox active copper: relevance to disease of glycooxidative stress. Biochem. Biophys. Res. Commun. 260:1999;332-338.
33. Saxena P., Saxena A.K., Cui X.L., Obrenovich M., Gudipathy K., Monnier V.M. Transition metal-catalyzed oxidation of ascorbate in human cataract extracts: possible role of advanced glycation end products. Investig. Opthalmol. Vis. Sci. 41:2000;1473-1481.
34. Schmidt A.M., Hori O., Chen J.X., Li J.F., Crandall J., Zhang J., Yan S.D., Brett J., Stern D. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for accelerated vasculopathy of diabetes. J. Clin. Invest. 96:1995;1395-1403.
35. Somers P.K., Medford R.M., Saxena U. Dithiocarbamates: effects of lipid hydroperoxides and vascular inflammatory gene expression. Free Radic. Biol. Med. 28:2000;1532-1537.
36. Suzuki Y.J., Tsuchiya M., Packer L. Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species. Free Radic. Res. Commun. 15:1991;255-263.
37. Vallejo S., Angulo J., Peiró C., Cercas E., Sánchez-Ferrer A., Nevado J., Llergo J.L., Rodríguez-Manas L., Sánchez-Ferrer C.F. Treatment with acarbose may improve endothelial dysfunction in streptozotocin-induced diabetic rats. J. Cardiovasc. Pharmacol. 36:2000;255-262.
38. Vlassara H., Fuh H., Makita Z., Krungkrai S., Cerami A., Bucala R. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc. Natl. Acad. Sci. U. S. A. 89:1992;12043-12047.
39. Yoshida A., Yoshida S., Ishibashi T., Kuwano M., Inomata H. Suppression of retinal neovascularization by the NF-κB inhibitor pyrrolidine dithiocarbamate in mice. Investig. Opthalmol. Vis. Sci. 40:1999;1624-1629.
40. Young I.S., Tate S., Lightbody J.H., McMaster D., Trimble E.R. The effect of desferrioxamine and ascorbate on oxidative stress in the streptozotocin diabetic rat. Free Radic. Biol. Med. 18:1995;533-540.
41. Ziegler D., Hanefeld M., Ruhnau K.J., Meissner H.P., Lobisch M., Schutte K., Gries F.A. The ALADIN Study Group. Treatment of symptomatic diabetic peripheral neuropathy with the antioxidant α-lipoic acid. Diabetologia. 38:1995;1425-1433.
42. Ziegler D., Schatz H., Conrad F., Gries F.A., Ulrich H., Richel G. Effect of treatment with the antioxidant α-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study), Deutsche Kardiale Autonome Neuropathie. Diabetes Care. 20:1997;369-373.